CEO of CODEXIS (CDXS) receives 993,000-share stock option grant

Rhea-AI Filing Summary

MOORE ALISON reported acquisition or exercise transactions in this Form 4 filing.

CODEXIS, INC. President and CEO Alison Moore reported receiving a stock option award covering 993,000 shares of the company’s stock. The award was granted as a derivative security with no cash purchase on the grant date.

According to the terms, the option vests over four years: 25% of the shares vest on the first anniversary of the grant date, and 1/48th of the original 993,000 shares vests on each monthly anniversary thereafter. Vesting is conditioned on Dr. Moore’s continued employment through the applicable vesting dates.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MOORE ALISON

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	993,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 993,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOORE ALISON

(Last) (First) (Middle)

C/O CODEXIS, INC.

200 PENOBSCOT DRIVE

(Street)

REDWOOD CITY CA 94063

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.07	02/23/2026		A		993,000		(1)	02/23/2036	Common Stock	993,000	$0	993,000	D

Explanation of Responses:

1. This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates.

	/s/ Georgia Erbez, as Attorney-in-Fact for Alison Moore	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CODEXIS (CDXS) disclose in this Form 4 filing?

CODEXIS reported that President and CEO Alison Moore received a stock option covering 993,000 shares. The derivative award involves no cash purchase at grant and is part of her equity-based compensation, aligning her interests with long-term company performance through future vesting.

How many CODEXIS (CDXS) shares are covered by Alison Moore’s new option?

The option grant covers 993,000 shares of CODEXIS common stock. This entire amount is subject to a multi-year vesting schedule, meaning Dr. Moore only gains exercisable rights to portions of these shares over time as specific vesting dates are reached.

What is the vesting schedule for Alison Moore’s 993,000-share option at CODEXIS (CDXS)?

The option vests 25% of the shares on the first anniversary of the grant date. The remaining shares vest in equal 1/48th installments each month thereafter, so full vesting occurs over four years if she remains continuously employed.

Is Alison Moore’s new CODEXIS (CDXS) option immediately exercisable?

No, the option is not fully exercisable at grant. Only after 25% vests on the first anniversary, and then 1/48th of the original total vests monthly, does she gain incremental exercisable rights, all conditioned on continued employment throughout the vesting period.

Does the Form 4 indicate any sale of CODEXIS (CDXS) shares by Alison Moore?

The filing reports an acquisition of a stock option award, not a sale of shares. The transaction code is “A,” described as a grant, award, or other acquisition, and involves a derivative security rather than an open-market purchase or disposition of existing common stock.

How is the ownership of the new option reported for CODEXIS (CDXS) CEO Alison Moore?

The Form 4 reports the option as directly owned by Alison Moore. After this grant, the total number of derivative securities reported for her in this specific option series is 993,000, reflecting the full amount of the newly awarded stock option.